Helder André
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Ocular Oncology and Treatments
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Retinal Diseases and Treatments 20
- Glaucoma and retinal disorders 12
- Ocular Oncology and Treatments 4
-
- Retinal Development and Disorders 11
- Angiogenesis and VEGF in Cancer 9
- CRISPR and Genetic Engineering 5
- Co-authors
- Anders Kvanta (32 shared papers)Monica Aronsson (17 shared papers)Effat Alizadeh (7 shared papers)Hammurabi Bartuma (6 shared papers)Sandra Petrus-Reurer (6 shared papers)Teresa Pereira (3 shared papers)Fredrik Lanner (5 shared papers)Emma Lardner (8 shared papers)
In The Last Decade
Helder André
60 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Ophthalmology 373
- Cancer Research 176
- Neurology 76
- Molecular Biology 531
- Radiology, Nuclear Medicine and Imaging 149
Countries citing papers authored by Helder André
This map shows the geographic impact of Helder André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helder André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helder André more than expected).
Fields of papers citing papers by Helder André
This network shows the impact of papers produced by Helder André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helder André. The network helps show where Helder André may publish in the future.
Co-authors
The 25 scholars most cited alongside Helder André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 98 | |
| 2 | 2020 | 75 | |
| 3 | 2015 | 62 | |
| 4 | 2019 | 60 | |
| 5 | 2020 | 51 | |
| 6 | 2015 | 49 | |
| 7 | 2017 | 48 | |
| 8 | 2018 | 37 | |
| 9 | 2019 | 37 | |
| 10 | 2021 | 36 | |
| 11 | 2014 | 35 | |
| 12 | 2020 | 31 | |
| 13 | 2016 | 30 | |
| 14 | 2020 | 28 | |
| 15 | 2015 | 28 | |
| 16 | 2020 | 27 | |
| 17 | 2021 | 25 | |
| 18 | 2019 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2016 | 22 |
About Helder André
Helder André is a scholar working on Ophthalmology, Molecular Biology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (20 papers), Glaucoma and retinal disorders (12 papers), Retinal Development and Disorders (11 papers), Angiogenesis and VEGF in Cancer (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), CRISPR and Genetic Engineering (5 papers), Ocular Oncology and Treatments (4 papers) and Cholesterol and Lipid Metabolism (3 papers). The work is most often cited by research in Ophthalmology (373 citations), Cancer Research (176 citations), Neurology (76 citations), Molecular Biology (531 citations) and Radiology, Nuclear Medicine and Imaging (149 citations). Helder André has collaborated with scholars based in Sweden, Spain and Italy. Frequent co-authors include Anders Kvanta, Monica Aronsson, Effat Alizadeh, Hammurabi Bartuma, Sandra Petrus-Reurer, Teresa Pereira, Fredrik Lanner, Emma Lardner, Álvaro Plaza Reyes and Kari Alitalo. Their work appears in journals such as Acta Ophthalmologica, Investigative Ophthalmology & Visual Science, Experimental Eye Research, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.